All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-37681020

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37681020	A1762T	BCP		Carcinoma, Hepatocellular	G R I C L	View
2	37681020	G1764A	BCP		Carcinoma, Hepatocellular	G R I C L	View
3	37681020	A162G	PreC	C	Carcinoma, Hepatocellular	G R C L	View
4	37681020	A633G	PreC;C	C	Carcinoma, Hepatocellular	G R C L	View
5	37681020	C1155T	P	P	Carcinoma, Hepatocellular	G R C L	View
6	37681020	C2567T	P	P	Carcinoma, Hepatocellular	G R C L	View
7	37681020	C3026T	X	X	Carcinoma, Hepatocellular	G R C L	View
8	37681020	C3051T	X	X	Carcinoma, Hepatocellular	G R C L	View
9	37681020	T2170C	C	C	Carcinoma, Hepatocellular	G R C L	View
10	37681020	T2857C	PreS2	S	Carcinoma, Hepatocellular	G R C L	View
11	37681020	C1653T	BCP		Carcinoma, Hepatocellular	G R C L	View
12	37681020	T1753V	BCP		Carcinoma, Hepatocellular	G R C L	View
13	37681020	A514C	S	S	Carcinoma, Hepatocellular	G R C L	View
14	37681020	C446G	S	S	Carcinoma, Hepatocellular	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.